Table 2 Comparison of patient characteristics between the flurbiprofen group and non-flurbiprofen group
Flurbiprofen group (n = 31) | Non-flurbiprofen group (n = 110) | p value | |
|---|---|---|---|
Age (year) | 48 ± 15 (21-84) | 49 ± 13 (24-84) | 0.850 |
Body mass index (kg/m2) | 25.0 ± 6.1 (16.4-46.1) | 23.3 ± 4.3 (16.0-36.0) | 0.155 |
Co-morbidities | |||
Hypertension | 8 (25.8) | 18 (16.4) | 0.231 |
Diabetes mellitus | 2 (6.5) | 6 (5.5) | 0.832 |
Bronchial asthma | 2 (6.5) | 17 (15.5) | 0.195 |
Malignancy | 17 (54.8) | 53 (48.2) | 0.513 |
Operation time (min) | 140 ± 56 (47-319) | 144 ± 56 (55-356) | 0.703 |
Anesthesia time (min) | 199 ± 60 (108-381) | 207 ± 67 (103-458) | 0.429 |
Blood loss (g) | 438 ± 539 (5-2316) | 452 ± 556 (6-3519) | 0.831 |
Fluid infusion (ml/kg/h) | 9.9 ± 3.7 (5.2-16.5) | 8.7 ± 3.0 (3.4-16.7) | 0.169 |
Fentanyl dosage (μg/kg) | 4.4 ± 1.9 (1.3-10.9) | 4.4 ± 1.7 (0.9-9.8) | 0.685 |
Remifentanil dosage (mg) | 1.9 ± 1.0 (0.8-6.0) | 2.0 ± 0.9 (0.8-6.0) | 0.616 |
Body temperature (°C) | |||
Highest body temperature | 36.8 ± 0.4 (36.1-38.0) | 36.8 ± 0.4 (35.8-37.8) | 0.614 |
Lowest body temperature | 36.4 ± 0.4 (35.5-37.2) | 36.3 ± 0.4 (35.1-37.3) | 0.431 |
Epidural analgesia | 26 (83.9) | 101 (91.8) | 0.191 |
Postanesthetic shivering | 2 (6.5) | 28 (25.5) | 0.022 |